pocketful logo light
pocketful logo light
Quick Heal Technologies Ltd logo

Quick Heal Technologies Ltd

NSE: QUICKHEAL BSE: 539678

₹175.03

(0.62%)

Tue, 16 Jun 2026, 09:43 am

Quick Heal Technologies Price to Sales Ratio (P/S)

Particulars20112012201320142015201620172018201920202021202220232024
Price to earnings ratio000023.4531.3322.5317.337.1611.2112.74116.74104.96313.70
Price to book ratio00002.422.512.582.020.811.591.641.685.763.51
Price to sales ratio00004.505.565.875.051.863.603.102.698.725.66
Price to cash flow ratio000016.3827.9016.5118.086.1311.2412.7222.87131.960
Enterprise value0000978Cr1282Cr1418Cr1097Cr178Cr731Cr707Cr559Cr2324Cr1388Cr
Enterprise value to EBITDA ratio00009.4913.9111.088.461.905.076.46114.09117.130
Debt to equity ratio00000000000000
Return on equity %031.0518.9116.2112.058.3911.9812.1310.3815.3312.061.225.661.15

Quick Heal Technologies Ltd Price to Sales Ratio

The Quick Heal Technologies Ltd Price to Sales Ratio is a key financial metric used by investors to evaluate Quick Heal Technologies Ltd's valuation, profitability, and overall financial performance. Tracking the Quick Heal Technologies Ltd Price to Sales Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.

Quick Heal Technologies Ltd (NSE: QUICKHEAL, BSE: 539678) is currently trading at ₹175.03, with a market capitalization of ₹946.36Cr. As a leading company in the Technology services sector and Packaged software industry, monitoring the Quick Heal Technologies Ltd Price to Sales Ratio is essential for fundamental analysis.

Quick Heal Technologies Ltd Price to Sales Ratio Current Value

The current Quick Heal Technologies Ltd Price to Sales Ratio stands at 5.66.

The Quick Heal Technologies Ltd Price to Sales Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.

Quick Heal Technologies Ltd Price to Sales Ratio Historical Trend

The Quick Heal Technologies Ltd Price to Sales Ratio has shown the following historical trend:

  • 2024: 5.66
  • 2023: 8.72
  • 2022: 2.69
  • 2021: 3.10
  • 2020: 3.60

The decline in Quick Heal Technologies Ltd Price to Sales Ratio indicates improving financial efficiency or better earnings growth.

What Quick Heal Technologies Ltd Price to Sales Ratio Indicates for Investors

The Quick Heal Technologies Ltd Price to Sales Ratio plays a crucial role in understanding the company's financial health and valuation.

The P/S ratio helps evaluate valuation relative to company revenue.

Quick Heal Technologies Ltd Price to Sales Ratio Analysis Summary

The Quick Heal Technologies Ltd Price to Sales Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Quick Heal Technologies Ltd Price to Sales Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.

Regular tracking of Quick Heal Technologies Ltd Price to Sales Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.

Open Your Free Demat Account

Enter your phone number